OptimizeRx (OPRX) EBIAT: 2010-2025
Historic EBIAT for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $779000.0.
- OptimizeRx's EBIAT rose 10853.79% to $779000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $34000.0, marking a year-over-year increase of 10014.07%. This contributed to the annual value of -$20.1 million for FY2024, which is 1448.25% down from last year.
- Per OptimizeRx's latest filing, its EBIAT stood at $779000.0 for Q3 2025, which was up 10853.79% from $1.5 million recorded in Q2 2025.
- OptimizeRx's 5-year EBIAT high stood at $1.5 million for Q2 2025, and its period low was -$9.1 million during Q3 2024.
- In the last 5 years, OptimizeRx's EBIAT had a median value of -$2.9 million in 2023 and averaged -$2.6 million.
- In the last 5 years, OptimizeRx's EBIAT crashed by 879000.85% in 2022 and then surged by 13822.36% in 2025.
- Over the past 5 years, OptimizeRx's EBIAT (Quarter) stood at $623462.0 in 2021, then tumbled by 152.26% to -$325836.0 in 2022, then tumbled by 1171.19% to -$4.1 million in 2023, then soared by 98.12% to -$78000.0 in 2024, then skyrocketed by 1098.72% to $779000.0 in 2025.
- Its EBIAT was $779000.0 in Q3 2025, compared to $1.5 million in Q2 2025 and -$2.2 million in Q1 2025.